Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Safeguard International Fund (SIF) was a private equity fund managed by the Safeguard International Group, focusing primarily on the specialty metals, chemicals, and materials sectors. Founded by Heinz Schimmelbusch and Arthur Spector, the fund specialized in acquiring and consolidating industrial companies to create global leaders in niche markets. Notable investments included Aleris International, Metallurg, and Titanium Metals Corporation (TIMET). While the fund shared historical ties and leadership with Safeguard Scientifics, its investment mandate was distinctively industrial rather than healthcare or technology-focused.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Safeguard International Fund.